+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Lipoxygenase Products of Arachidonic Acid Stimulate LHRH Release from Rat Median Eminence

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Exogenous arachidonic acid (AA) incubated in presence of male rat hypothalamus, shows a low rate of conversion (<1%) of the substrate with a major product, identified as 12-hydroxyeicosatetraenoic acid (12-HETE) by reverse phase-high performance liquid chromatography (rpHPLC) and gas chromatography-mass spectrometry (GC-MS). Furthermore, immunoreactive 12-HETE estimated after purification on rpHPLC is produced by hypothalamus slices or median eminences (MEs) incubated in absence of any exogenous precursor. The effect of 12-HETE was tested on the release of LHRH from rat MEs after a 30-min incubation and was compared to the effect of another lipoxygenase product, 5-HETE, and to the well-known stimulatory effect of prostaglandin E<sub>2</sub> (PGE2). The three AA metabolites stimulate LHRH release. A significant stimulatory effect on LHRH release is obtained with 10<sup>–9</sup> M of 12-HETE and only with 10<sup>–8</sup> M of 5-HETE or PGE2. Furthermore, the effect of higher concentrations is different according to the eicosanoid tested. The maximal response (176% of the control) is reached with 12-HETE at 10-<sup>8</sup> M No significant change is observed at 10<sup>–7</sup> and 10<sup>–6</sup> M The response with 5-HETE is also maximal (162% of the control) at 10<sup>–8</sup> M but decreases significantly (only 117% of the control) at 10"<sup>6</sup> M The amplitude of the response to PGE2 is larger and higher, reaching a plateau (300% of the control) at 10<sup>–6</sup> M 12-HETE has no effect on somatostatin (SRIF) release, as already known for PGE2. These results are the first evidence of selective effect of lipoxygenase products on the release of neuropeptides from rat hypothalamus. The identification of 12-HETE as endogenous metabolite is in favor of a physiological role of the compound.

          Related collections

          Author and article information

          S. Karger AG
          28 March 2008
          : 40
          : 3
          : 272-276
          aU-207, Inserm, Institut Pasteur Uria, Paris, France; bLaboratory of Clinical Science, Section of Pharmacology, NIH, Bethesda, Md.; cDepartment of Pharmacology, University of Colorado, Medical School, Denver, Colo., USA
          124084 Neuroendocrinology 1985;40:272–276
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Original Paper


          Comment on this article